Articles from Verantos

Verantos today announced it ranked 444 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 31st year. It was the only real-world evidence-focused company on the list.

Verantos, the global leader in high-validity real-world evidence at scale, announced today that it will present practical approaches for generating high-validity real-world evidence (RWE) at the International Society for Pharmacoepidemiology (ISPE) 41st Annual Meeting in Washington, D.C.

Verantos, the global leader in high-validity real-world evidence (RWE) for the life sciences, marks its fourth consecutive appearance on the Inc. 5000, ranking No. 2405 on the most prestigious list of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, and Patagonia.

Verantos, the global leader in high-validity real-world evidence at scale, today announced the publication “Implementing Accuracy, Completeness, and Traceability for Data Reliability” in JAMA Network Open. The study, written in collaboration with a consortium of academic and industry leaders, proposes a reproducible framework for measuring and optimizing the reliability of real-world data (RWD).

Verantos today announced it ranked 319 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 30th year. Verantos grew 368% during this period.